Starzl T E, Porter K A, Putnam C W, Schroter G P, Halgrimson C G, Weil R, Hoelscher M, Reid H A
Surg Gynecol Obstet. 1976 Apr;142(4):487-505.
During the 11 1/2 year period ending 13 months ago, 93 consecutive patients were treated with orthotopic liver transplantation. Fifty-six of the recipients were 18 years old or younger, and the other 37 were adults. The most common indications for operation were biliary atresia, primary hepatic malignant tumor, chronic aggressive hepatitis and alcoholic cirrhosis. There has been a gradual improvement in results throughout the period of study, although to a satisfactory level. Twenty-seven of the 93 patients survived for at least one year after liver replacement with a maximum of six years, and 16 are still alive after 13 to 71 months. The 11 late deaths after one to six years were caused by chronic rejection, biliary obstruction, recurrence of hepatoma, systemic infection or hepatitis of the homograft. Rejection of the liver as judged by classical histopathologic criteria played a surprisingly small role in the heavy over-all mortality, accounting for less than 10 per cent of the deaths. Technical or mechanical problems, especially those of biliary duct reconstruction, were a far greater cause of failure, as were systemic infections. Six of the 37 adult recipients had lethal cerebrovascular accidents during, or just after, operation. When abnormalities of liver function developed in the postoperative period, the nearly automatic diagnosis of homograft rejection, in retrospect, proved to have been wrong in most instances. Further development of liver transplantation depends upon two kinds of progress. There must be reduction of operative and early postoperative accidents and complications by more discriminating patient selection, purely technical improvement and better standardization of biliary duct reconstruction. The second area will be in sharpening the criteria for the differnetial diagnosis of postoperative hepatic malfunction, including the liberal use of transhepatic cholangiography and needle biopsy. Only then can better decisions be made about changes in medication or about the need for secondary corrective surgical procedures.
在截至13个月前的11年半时间里,93例患者接受了原位肝移植治疗。其中56例受者年龄在18岁及以下,另外37例为成年人。最常见的手术指征是胆道闭锁、原发性肝脏恶性肿瘤、慢性侵袭性肝炎和酒精性肝硬化。在整个研究期间,结果有逐渐改善,尽管达到了令人满意的水平。93例患者中有27例在肝移植后存活至少一年,最长达六年,16例在13至71个月后仍存活。1至6年后的11例晚期死亡是由慢性排斥反应、胆道梗阻、肝癌复发、全身感染或同种异体肝肝炎引起的。根据经典组织病理学标准判断的肝脏排斥反应在总体高死亡率中所起的作用出人意料地小,占死亡人数的不到10%。技术或机械问题,尤其是胆管重建问题,是导致失败的一个重要得多的原因,全身感染也是如此。37例成年受者中有6例在手术期间或刚手术后发生致命的脑血管意外。当术后出现肝功能异常时,回顾起来,几乎自动诊断为同种异体肝排斥反应在大多数情况下被证明是错误的。肝移植的进一步发展取决于两方面的进展。必须通过更严格的患者选择、纯粹的技术改进和更好的胆管重建标准化来减少手术及术后早期的意外和并发症。第二个方面将是完善术后肝功能障碍鉴别诊断的标准,包括更广泛地使用经肝胆管造影和针吸活检。只有这样,才能在药物调整或二次矫正手术需求方面做出更好的决策。